Antibody Discovery, Selection and Screening Digital Week

Valentine de Puyraimond, MSc, will be presenting “Combating COVID-19: Identifying a Potential Drug Candidate for Human Testing in 90 Days” at Antibody Discovery, Selection and Screening Digital Week.

For more information on AbCellera’s response to COVID-19, click here

MaRS Impact Health

Véronique Lecault, Ph.D., Co-founder and Chief Operating Officer, will be participating in a roundtable session discussing how health companies are building, scaling and tackling adoption challenges today in Canada.

Biologics Europe: Online

Stefanie Zentelis, Ph.D., will be presenting “Combating COVID-19: Identifying a Potential Drug Candidate for Human Testing in 90 Days” at Biologics Europe: Online.

For more information on AbCellera’s response to COVID-19, click here.

Festival of Biologics USA

Christopher Williamson, Ph.D., Senior Research Scientist and Project Lead will be presenting “Amplifying antibody diversity with single-cell screening and immune repertoire sequencing” at the Festival of Biologics USA.

PEGS Europe Virtual

Christopher Williamson, Ph.D., Senior Scientist and Project Lead will be presenting “Amplifying Antibody Diversity – Single-Cell Screening Combined with Repertoire Sequencing from Humanized Mice” at the Protein & Antibody Engineering Summit.

BC Cancer Research Day

Stefanie Žentelis will be representing AbCellera at the BC Cancer Research Day 2020, hosted by the BC Cancer Graduate Student and Postdoctoral Fellow Society.

PepTalk 2020

AbCellera has successfully completed several antibody discovery programs targeting GPCRs and ion channels. Marta presented insights on AbCellera’s innovative approach in her talk “Against Nature: How to Hack Immune Systems to Discover Antibodies that Target Complex Membrane Proteins”

LifeSciences BC’s Blakes Breakfast

The Blakes Breakfast Speaking Series is LifeSciences BC’s longest-standing event series, bringing together local, national and multinational life science companies. This month, a panel of speakers contributed to a discussion themed “Understanding the COVID-19 virus and how BC is leading the fight”. Senior Research Scientist Kathryn Westendorf presented AbCellera’s efforts in her talk “Making an Antibody-Based Therapeutic in 60 Days: High-Throughput Discovery Applied to a Rapid Pandemic Response Platform”.

Festival of Biologics 2020

Using clever immunization strategies and screening millions of single B cells, AbCellera has found and validated hundreds of ultra-low frequency and highly diverse antibodies. Senior Research Scientist, Christopher Williamson presented “Ultra-rare but there: natural and diverse antibodies against high homology targets” in the Protein Engineering stream at this year’s Festival of Biologics.